Social Media Ideas for Anvisa

Biosimilars in Brazil: Intellectual Property, Regulatory and Market Landscape

Biological drugs, or biologics, are now a well-established class of therapeutic products worldwide. Unlike conventional small-molecule drugs, which are generally obtained through c...

Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection

Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health O...

Alerta sanitaria por Perjeta falsificado en Venezuela: este es el lote que no debe utilizarse

Perjeta falsificado en Venezuela. El Servicio Autónomo de Contraloría Sanitaria (SACS) emitió una alerta tras detectar la comercialización ilegal de unidades falsificadas de Perjet...

<![CDATA[Novo Announces Drug Discovery Collaboration with Anthropic ]]>

ANAV aplaude chumbo europeu à compra da Etraveli pela Booking e alerta para risco de concentração

Associação considera decisão do Tribunal da UE fundamental para preservar concorrência no Turismo. Em comunicado divulgado esta quarta-feira, 10 de setembro, em Lisboa, a associaçã...

Poison Centre Notification Compliance: Distributor Obligations and Clarification of UFI Requirements for Imported Mixtur...

Authorities probing ‘counterfeit’ rabies vaccine, says drug regulator

The manufacturer of the vaccine has denied producing the ‘misbranded’ vials bearing batch number KE25012 which failed a potency test by the Central Drugs Laboratory

Health Ministry approves biovigilance programme to monitor adverse drug reactions

The programme will focus on reporting, assessment, monitoring and prevention of adverse events associated with medicines and biological products used in organ and tissue transplant